NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure

Hospital General Universitario Morales Meseguer

Status: Unknown

Conditions: Respiratory Failure; Covid-19

Treatments: Other: Evaluate HACOR score effectivity in this patients; Other: Monitoring for aggravation

Study type: Observational

Funder types: Other

Identifiers

NCT04342104

08-04-2020

Details and patient eligibility

About

Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.

Propose adaptations to HACOR score based on the "state of art" of COVID-19

Full description

Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.

Propose adaptations to HACOR score based on the "state of art" of COVID-19

• this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with acute respiratory failure due to COVID-19 who have initiated NIV or CPAP based on assistant clinician decision

Exclusion criteria

• Patients with imediate indication to invasive mechanical ventilation
• Patients with any formal contraindication to noninvasive respiratory support

Trial design

100 participants in 2 patient groups

NIV

Description:

Patients on Bilevel NIV

Treatment:

Other: Monitoring for aggravation

Other: Evaluate HACOR score effectivity in this patients

CPAP

Description:

Patients on CPAP

Treatment:

Other: Monitoring for aggravation

Other: Evaluate HACOR score effectivity in this patients